Insider Transactions in Q3 2018 at Bristol Myers Squibb CO (BMY)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Sep 03 2018	Adam Dubow SVP,ChiefCompliance&EthicsOff.	SELL Payment of exercise price or tax liability	Direct	273 -1.76%	$16,380 $60.55 P/Share
Sep 03 2018	Adam Dubow SVP,ChiefCompliance&EthicsOff.	BUY Exercise of conversion of derivative security	Direct	797 +4.89%	-
Sep 01 2018	Karen Murphy Santiago SVP & Controller	SELL Payment of exercise price or tax liability	Direct	220 -5.42%	$13,200 $60.55 P/Share
Sep 01 2018	Karen Murphy Santiago SVP & Controller	BUY Exercise of conversion of derivative security	Direct	641 +13.64%	-
Aug 01 2018	Murdo Gordon EVP, Chief Commercial Officer	SELL Payment of exercise price or tax liability	Direct	744 -1.48%	$43,896 $59.62 P/Share
Aug 01 2018	Murdo Gordon EVP, Chief Commercial Officer	BUY Exercise of conversion of derivative security	Direct	1,510 +2.92%	-
Jul 01 2018	Paul Biondi SVP, Head of Strategy & BD	SELL Payment of exercise price or tax liability	Direct	720 -49.28%	$39,600 $55.34 P/Share
Jul 01 2018	Paul Biondi SVP, Head of Strategy & BD	BUY Exercise of conversion of derivative security	Direct	1,461 +50.0%	-

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Value

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

Operation

Value

Type

Receive news related to BRISTOL MYERS SQUIBB CO